1
|
Emilsson ÖI, Sundbom F, Ljunggren M, Benediktsdottir B, Garcia-Aymerich J, Bui DS, Jarvis D, Olin AC, Franklin KA, Demoly P, Lindberg E, Janson C, Aspelund T, Gislason T. Association between lung function decline and obstructive sleep apnoea: the ALEC study. Sleep Breath 2020; 25:587-596. [PMID: 32632893 PMCID: PMC8195766 DOI: 10.1007/s11325-020-02086-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Revised: 03/31/2020] [Accepted: 04/13/2020] [Indexed: 11/25/2022]
Abstract
Purpose To study changes in lung function among individuals with a risk of obstructive sleep apnoea (OSA), and if asthma affected this relationship. Methods We used data from the European Community Respiratory Health Survey II and III, a multicentre general population study. Participants answered questionnaires and performed spirometry at baseline and 10-year follow-up (n = 4,329 attended both visits). Subjects with high risk for OSA were identified from the multivariable apnoea prediction (MAP) index, calculated from BMI, age, gender, and OSA symptoms at follow-up. Asthma was defined as having doctor’s diagnosed asthma at follow-up. Primary outcomes were changes in forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) from baseline to follow-up. Results Among 5108 participants at follow-up, 991 (19%) had a high risk of OSA based on the MAP index. Participants with high OSA risk more often had wheeze, cough, chest tightness, and breathlessness at follow-up than those with low OSA risk. Lung function declined more rapidly in subjects with high OSA risk (low vs high OSA risk [mean ± SD]: FEV1 = − 41.3 ± 24.3 ml/year vs − 50.8 ± 30.1 ml/year; FVC = − 30.5 ± 31.2 ml/year vs − 45.2 ± 36.3 ml/year). Lung function decline was primarily associated with higher BMI and OSA symptoms. OSA symptoms had a stronger association with lung function decline among asthmatics, compared to non-asthmatics. Conclusion In the general population, a high probability of obstructive sleep apnoea was related to faster lung function decline in the previous decade. This was driven by a higher BMI and more OSA symptoms among these subjects. The association between OSA symptoms and lung function decline was stronger among asthmatics. Electronic supplementary material The online version of this article (10.1007/s11325-020-02086-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Össur Ingi Emilsson
- Department of Respiratory, Allergy and Sleep Research, Akademiska Sjukhuset, Uppsala University, 751 85, Uppsala, Sweden. .,Department of Respiratory Medicine and Allergology, Akademiska Sjukhuset, Uppsala, Sweden.
| | - Fredrik Sundbom
- Department of Respiratory, Allergy and Sleep Research, Akademiska Sjukhuset, Uppsala University, 751 85, Uppsala, Sweden.,Department of Respiratory Medicine and Allergology, Akademiska Sjukhuset, Uppsala, Sweden
| | - Mirjam Ljunggren
- Department of Respiratory, Allergy and Sleep Research, Akademiska Sjukhuset, Uppsala University, 751 85, Uppsala, Sweden.,Department of Respiratory Medicine and Allergology, Akademiska Sjukhuset, Uppsala, Sweden
| | - Bryndis Benediktsdottir
- Department of Sleep Medicine, Landspitali, Reykjavik, Iceland.,Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Judith Garcia-Aymerich
- ISGlobal, Barcelona, Spain.,Universitat Pompeu Fabra (UPF), Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
| | - Dinh Son Bui
- Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia
| | - Deborah Jarvis
- National Heart and Lung Institute, Imperial College London, London, UK
| | - Anna-Carin Olin
- Unit of Occupational and Environmental Medicine, University of Gothenburg, Gothenburg, Sweden
| | - Karl A Franklin
- Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden
| | - Pascal Demoly
- Department of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France.,Inserm, Sorbonne Université, Equipe EPAR - IPLESP, Paris, France
| | - Eva Lindberg
- Department of Respiratory, Allergy and Sleep Research, Akademiska Sjukhuset, Uppsala University, 751 85, Uppsala, Sweden.,Department of Respiratory Medicine and Allergology, Akademiska Sjukhuset, Uppsala, Sweden
| | - Christer Janson
- Department of Respiratory, Allergy and Sleep Research, Akademiska Sjukhuset, Uppsala University, 751 85, Uppsala, Sweden.,Department of Respiratory Medicine and Allergology, Akademiska Sjukhuset, Uppsala, Sweden
| | - Thor Aspelund
- Centre for Public Health Sciences, University of Iceland, Reykjavik, Iceland
| | - Thorarinn Gislason
- Department of Sleep Medicine, Landspitali, Reykjavik, Iceland.,Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| |
Collapse
|